Back
Northwest Biotherapeutics, Inc. 10K Form
Sell
42
NWBO
Northwest Biotherapeutics, Inc.
Last Price:
$0.25
Seasonality Move:
24.69%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-10 | 10Q | NWBO/Northwest Biotherapeutics, Inc. Quarterly |
| 2023-11-09 | 10Q | NWBO/Northwest Biotherapeutics, Inc. Quarterly |
| 2023-08-09 | 10Q | NWBO/Northwest Biotherapeutics, Inc. Quarterly |
| 2023-05-10 | 10Q | NWBO/Northwest Biotherapeutics, Inc. Quarterly |
| 2022-11-09 | 10Q | NWBO/Northwest Biotherapeutics, Inc. Quarterly |
| 2022-08-09 | 10Q | NWBO/Northwest Biotherapeutics, Inc. Quarterly |
Receive NWBO News And Ratings
See the #1 stock for the next 7 days that we like better than NWBO
NWBO Financial Statistics
Sales & Book Value
| Annual Sales: | $1.4M |
|---|---|
| Cash Flow: | $-14.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.07 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -0.06580 |
|---|---|
| Net Income (TTM): | $-89.8M |
| Gross Margin: | $-662K |
| Return on Equity: | 0% |
| Return on Assets: | -311.49% |
Northwest Biotherapeutics, Inc. Earnings Forecast
Key Northwest Biotherapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 28 years for NWBO is -47.90%.
-
The Selling, General & Administrative Expenses for NWBO have been equal to 2,387.99% of Gross Profit Margin.
-
The Research & Development expenses have been 2,524.46% of Revenue.
-
The Net Earning history of NWBO is -6,062.08% of Total Revenues.
-
Per Share Earnings over the last 28 years have been positive in 15 years.
Northwest Biotherapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | NWBO |
| CUSIP: | 66737P |
| Website: | nwbio.com |
Debt
| Debt-to-Equity Ratio: | -0.81 |
|---|---|
| Current Ratio: | 0.08 |
| Quick Ratio: | 0.05 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
NWBO Technical Analysis vs Fundamental Analysis
Sell
42
Northwest Biotherapeutics, Inc. (NWBO)
is a Sell
Is Northwest Biotherapeutics, Inc. a Buy or a Sell?
-
Northwest Biotherapeutics, Inc. stock is rated a SellThe current Northwest Biotherapeutics, Inc. [NWBO] share price is $0.25. The Score for NWBO is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.